9999999997-23-004614.txt : 20231031
9999999997-23-004614.hdr.sgml : 20231031
20231031170003
ACCESSION NUMBER: 9999999997-23-004614
CONFORMED SUBMISSION TYPE: SEC STAFF ACTION
CATEGORY: ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20231031
ACTION DATE: 20231031
RECEIVED DATE: 20231031
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mural Oncology plc
CENTRAL INDEX KEY: 0001971543
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SEC STAFF ACTION
BUSINESS ADDRESS:
STREET 1: 10 EARLSFORT TERRACE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 T380
BUSINESS PHONE: 353 1 905 8020
MAIL ADDRESS:
STREET 1: 10 EARLSFORT TERRACE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 T380
FORMER COMPANY:
FORMER CONFORMED NAME: Mural Oncology Ltd
DATE OF NAME CHANGE: 20230403
FORMER COMPANY:
FORMER CONFORMED NAME: Pistachiovale Ltd
DATE OF NAME CHANGE: 20230329
ORDER
1
filename1.pdf
begin 644 filename1
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M7Y:+.)J133R)HPU9S]3WR>!\%'2+D+:L,!(?XKFJW5$XL_1'9JN2X7;>M'Q=4@0F@JE
MHNGA-$W'+/"I$/ B1&GZMSY,"XSF)II^62_B!5SL9#DCT:_3SY/E8T2FJZ>G
MQ6:S6"WM]%WA4C]HO>NX.X0(?85>T0]P^J9C[@>4P9TYC'KH 838/9LVHSDG
MC)E'L$KK8IN51+ 'PATN[MVWH*&KO.E8-50(:1VSHCW&:;>+'?*1.23>W3)E
M#FKICSN:XGK30R+I(*":R.T,,"=R^Q#?'D]%?B NEL-_W?^#0^)!0$.AO&">
MT=/5W^KY$DEV^FK@Y^'T\*3C^Z$61#T=$7O4!*XRQ=S=.6^3M":?[GI^:XHQ)_\ Z(_&S\\-IE&\5MNV66L4S]3#
M-@F-9ODW];15NA:>'-,P!R0^#RF>X3FF.\-$I?CAT[E,CF1U2HMC\?Q.7H\I
M+CL6>)0%RH7IF+G4TDE@ZC),AI"\HJ0\5ONBK$FWTIS*]^V/KA<>
M(,K "GDXIN/@GC:08MHWTM2Q6L^B-9E%TW].UHOE(UE'CXM-O)[$UX[GEI+G
M>'0<&@@:,EJOBBBZA< X':.X!:+IOI&&.YK/HVF\^"4B/WU9;[Y,EC&)5V0C
MGZV6L.CK?U@X6 $++1UZ'T"6#CP06+!S\H?$2%IHE^Z'/93Q.MY^SZS,J24T\/:V,]!2
MXSP'HLOB[Y;JP!PY9^@[]=.(BTB/,4'Y/8 N(KV^D0;2<=A'EX4BL*#TO?YV
M-RA;?=F#HKLFVQ&KR'?Q-K5;;>_B7+RO]'C0DN[&A[_2R7?^L#W0)D]_JS/%
MN\YNM62*$[5HAOLW1._.29T!YL3>O[OX7.LYX<7R.YNVRS!3Z_#B6F3JB#^V
MIT#V%/>N3'MK]+RN1?ZV]1X^TQKKM0\F^ B*X7>AN?+P+P8>/B(J"TW^O^M_
M;IMKM#,XY-BY>7O*KRXD2@Z6P>+9-JE[R1QV.Q!0=/2?F?
MK(:7EL+'&?6Y!D?'"'T7T3+[+3TDI^?L@;R>R^JV-EH
M4HW8;!.0^=2_[5T]7/*NX)1;".*"51:V&(29/TG3HMPEIS2[!)U^';ON.HQC
M>6B>).?Z4%P/[;JHO6!;* H:CC54.E0&Z=Y"#D\"RF)X2+YE),UDXY*#=B"F
M>LJI#TDMG[V39BF$;EE\RRYJ2H])U1"H5 S M$F.$,[YZ9E81SU)9^QJ.'1P
MD$-UU$/PFRSE%79FF6MV'62N-O51NIZ;T+
M%F.?NL($9[]@'[U@9"SV\40A7(]7C:YDG=4;R2ZEXE1]>4O@?E!3I0=8^Z<5>&;@K"YS"I8/E'O5Q
M>@&N1F4Q!&CU-25"DLA/WP!.45:4 ,&R"< 'J'DDAZHGOP=$,TOX7FN@4;QM
M16Y,>:!AT($Q1KF%"M[.*(OAM56H#LGQ".>>%B^ZFO*7EVPG[^#X;JMW(9>]
MA('!&I0!QX(R$+=!&> YA(=05@5.%1>FLK %Y?P20II*'\CVO7D$*//J>LO3
MHGPMKOED'Q9JF^H]]\IT*_(01X=V*:W/F(8"S\WE>$H/L4KHW 9Z2H%'3
M$)B_U<-5KBR^_XFUY[\_EH>(^(0#/?==6,CHT#?2D&W._TM.IXQ\3MZSRE(V
M@C%E[BW4_KF& CG7$-7!E+T-A=&%L;V65S)RE6=MJ)#<0_17]0!A)526I83'$WET2
ME@W&-N1A\,/8;LR /;-XQDOR]SGJTESD3-IJ9S&MOM0YIZI4NHR6C#7!./;&
MD?$.M\'XSID4#04VJ3-LK>FL<=9Y(VC(&T:38&.8<\J2>$5X@+UT$ 4\<(0/:#M0XR]R9SQ,$L ^OPK9.4! 0K#O
M0C+D (734/86'GN8.(A[0#Q<]WCE10RD/=G.$)XI6 -ISXB98,_ $:0D\R:T
MX&7P!CC#H C1&X3B8R9%FS(O)%+ =\GYBH;!F_WA[!H^,ERRD0QG%Q$$0\K%
M8)!I\C 6N$#@08A$XHS@/5LR CL6?(=+8L7@$XD$(^ )X!7P1P2!5Q312SFT
M!-( ?$(>LTO6)H,0V>)!T(,.^4'JV$5TML %B"%D)O 'N)CS@4_,Z)0 >T$2
MH!>A'U(R>20(HR1$DY(1H1>BG@/^RY7 ^P[]'>R"!%)!H78C$,(
MNS
MB_5JVZ^V&X-:LN9J=O/WCWYVN7CL9U?]9OWZOOR>K^]7+P,E':F=WD49-OO_<-R<;[^:V[S:$%QQ<[?GIUE;ZY?
M[[99./F!#R58;K
MD#+,#?G:#5=GM7':*,0IQBG(*'<\L!P=3JQI-A_!TB$R+Z<3$N ]-)\&6\>"F
M0_QT"/T+,A8;9O2)]C+1_C!\I"77S8O)H0-VE?QY^7.4.=0P*K";SZ.H>F*B
MYMFOVT.H)6YZH]/:W^0FZM0#DUJ'#-%$G3>+AFW5D6DZ[#[2J[L=2-EZE-U"
M/77[W=QPLEN*WEDR))ZLJO=0]4(3
M&KL!3H[$W(UE)-BCC 3;DI%0+Z+2M<46W$CF&/3]!7KCHFNS?MX>H%_#U4/L]CZPS;M?ZC%W00WONK&-\EM7C+>%_+Z_O6Y7VU']SW:'<.U'!>6<\)R0%A^?Y43M]*4X[1RCE:.S,IY
M6#GL*OU<3JN.DW/DQ,U+WU^MU]N\_QTLRLEO?I__U\/F\V'S#U$(;8T*96YD
M)PET5520U$41-%S@[U@P1V"N[M[=Q
M,"0F^JA5Z8]5_;\C(L\+\1/?^$(@0P,2&E%$,YK0BA84T(X2:M"&;G2@$UV8
MPRQ&,(PA]* 7?>C' 8Q@U&4,8XQ3&("TYC"*E:P@'DL81'+6,<:MK&!36QA
M'WO8Q0Z.<81#'. <9SC%":Y0P24N<(=;W. :GWC& ^[QA$=\X!4O>,=;BE(U
M3VTJ_E9?'>I35HE(V5]8GO\#JW,S9@IE;F1S=')E86T*96YD;V)J"B5I5&5X
=="TU+C0N-0IS=&%R='AR968*,S@X- HE)45/1@H!
end